Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) fell 1.4% on Friday . The company traded as low as $4.79 and last traded at $4.84. 50,186 shares traded hands during trading, an increase of 110% from the average session volume of 23,861 shares. The stock had previously closed at $4.91.
Ono Pharmaceutical Price Performance
The firm has a 50-day simple moving average of $5.12 and a 200 day simple moving average of $4.52.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Featured Stories
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png){kind=logo}
